The DCF model implemented suggests that the company is undervalued by 59.19%. In 2024, Moncler achieved a 34.84% liabilities-to-assets ratio, a low value. This value suggests a low risk of bankruptcy.
My estimations suggest that the U.S. government's cuts to its healthcare system will not have a significant negative impact on West Pharmaceutical's revenues. In Q2 2025, the company's revenues ...